SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
697>>Erik posted to Valuation thread.>> It was a mistake by me. I don&Icebrg-11/18/2004
696Vaccinex and Biocon to Co-Develop Antibody Products <i>(Erik posted to Valnigel bates-11/18/2004
695Raven biotechnologies Files First Investigational New Drug Application (IND) TueIcebrg-11/16/2004
694Peptech now appear to have the funds (and settled TNF IP) to push ahead with thenigel bates-11/16/2004
693I'd <i>love</i> to see that lab.scaram(o)uche-11/9/2004
692European Molecular Biology Laboratory --EMBL-- and Abnova Corporation Announce PIcebrg-11/9/2004
691Peregrine Pharmaceuticals and Affitech AS Expand Collaboration to Develop Up to Icebrg-11/8/2004
690Affimed Therapeutics and Biopharma Unit of Syngenta Enter Into Agreement to Co-dIcebrg-11/6/2004
689ARIUS Research and Oxford BioMedica Extend Collaboration on Novel Cancer TargetsIcebrg-10/31/2004
688Dyax results - Message 20674160 ...Based on initial guidance received from the nigel bates-10/22/2004
687Peregrine Pharmaceuticals Announces Successful Completion of its Antibody HumaniIcebrg-10/18/2004
686Biolex Announces the Further Expansion if Its Collaboration With Centocor WednesIcebrg-10/6/2004
685GPC Biotech Presents Data on 1D09C3 Anticancer Monoclonal Antibody at EORTC-NCI-Icebrg-9/30/2004
684Biocon's cancer drug enters phase II trials TIMES NEWS NETWORK[ WEDNESDAY, SIcebrg-9/29/2004
683BioInvent and ThromboGenics Strike Alliance to Jointly Develop Antibody-Based ThIcebrg-9/28/2004
682Aphton and XOMA Form Therapeutic Antibody Collaboration for Treating GastrointesIcebrg-9/23/2004
681Roche licenses humanising antibody technology 21/09/2004 - Drug major Roche haIcebrg-9/21/2004
680<i>It will be interesting to see if the share price of Abgenix goes up todnigel bates-9/20/2004
679nope. (eom)scaram(o)uche-9/20/2004
678Ablynx and Genencor Form Oncology Collaboration GHENT, Belgium, Sept. 20 /PRNewnigel bates-9/20/2004
677Pfizer/Abgenix/Medarex A pretty tough blow for Abgenix if today's Medarex/PIcebrg-9/20/2004
676You didn't really expect me to be able to answer the question ? :-) In any nigel bates-9/20/2004
675wasn't talking about domain abs in particular, but about variants that are sscaram(o)uche-9/17/2004
674Domain antibodies in general ? Not according to Domantis, BWDIK. (Posted it as nigel bates-9/17/2004
673Yeah, but are they immunogenic? (eom)scaram(o)uche-9/17/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News